Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster lymph - node

Terms

95lymph
79node
49sentinel
28biopsy
15nodes
22malignant
31melanoma
21drainage

Associations

Freq.WeightAssociation
5252lymph - node
4343node - sentinel
3030lymph - sentinel
2727biopsy - sentinel
2727biopsy - node
1818biopsy - lymph
1313lymph - nodes
1414malignant - melanoma
1212melanoma - node
1212drainage - lymph
1010lymph - melanoma
77melanoma - sentinel
66nodes - sentinel
44malignant - node
44lymph - malignant

Documents par ordre de pertinence
000F05 (2000) S. P. Hettiaratchy [Royaume-Uni] ; N. Kang [Royaume-Uni] ; G. A. O'Toole [Royaume-Uni] ; B. W. E. M. Powell [Royaume-Uni] ; R. Allan [Royaume-Uni] ; M. G. Cook [Royaume-Uni]Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients
000058 (2017) J A Moody [Royaume-Uni] ; R F Ali [Royaume-Uni] ; A C Carbone [Royaume-Uni] ; S. Singh [Royaume-Uni] ; J T Hardwicke [Royaume-Uni]Complications of sentinel lymph node biopsy for melanoma - A systematic review of the literature.
000066 (2017) R M Parks [Royaume-Uni] ; K L Cheung [Royaume-Uni]Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
000096 (2016) Gianpiero Manca [Royaume-Uni] ; Elisa Tardelli ; Domenico Rubello ; Marta Gennaro ; Maria Cristona Marzola ; Gary J. Cook ; Duccio VolterraniSentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.
000120 (2016) Mirjam Cl Peek [Royaume-Uni] ; Tibor Kovacs [Royaume-Uni] ; Rose Baker [Royaume-Uni] ; Hisham Hamed [Royaume-Uni] ; Ash Kothari [Royaume-Uni] ; Michael Douek [Royaume-Uni]Is blue dye still required during sentinel lymph node biopsy for breast cancer?
000279 (2014) C. Meads [Royaume-Uni] ; A J Sutton [Royaume-Uni] ; A N Rosenthal [Royaume-Uni] ; S. Małysiak [Pologne] ; M. Kowalska [Pologne] ; A. Zapalska [Pologne] ; E. Rogozi Ska [Royaume-Uni] ; P. Baldwin [Royaume-Uni] ; R. Ganesan [Royaume-Uni] ; E. Borowiack [Royaume-Uni] ; P. Barton [Royaume-Uni] ; T. Roberts [Royaume-Uni] ; K. Khan [Royaume-Uni] ; S. Sundar [Royaume-Uni]Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis
000397 (2013) Metehan Gumus [Turquie] ; Hatice Gumus [Turquie] ; Sue E. Jones [Royaume-Uni] ; Peter A. Jones [Royaume-Uni] ; Ali R. Sever [Royaume-Uni] ; Jennifer Weeks [Royaume-Uni]How Long Will I Be Blue? Prolonged Skin Staining Following Sentinel Lymph Node Biopsy Using Intradermal Patent Blue Dye
000405 (2013) A J Sutton [Royaume-Uni] ; P. Barton [Royaume-Uni] ; S. Sundar [Royaume-Uni] ; C. Meads [Royaume-Uni] ; A N Rosenthal [Royaume-Uni] ; P. Baldwin [Royaume-Uni] ; K. Khan [Royaume-Uni] ; T E Roberts [Royaume-Uni]Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer
000437 (2013) J. M. Mcgregor [Royaume-Uni]Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands
000443 (2013) Amy Burger [Royaume-Uni] ; David Thurtle [Royaume-Uni] ; Sally Owen [Royaume-Uni] ; Gurdeep Mannu [Royaume-Uni] ; Simon Pilgrim [Royaume-Uni] ; Raman Vinayagam [Royaume-Uni] ; Simon Pain [Royaume-Uni]Sentinel Lymph Node Biopsy for Risk‐Reducing Mastectomy
000563 (2012) Ansar Farooq [Niger] ; Mysore Chandrshekar [Royaume-Uni] ; Kieran HorganRole of sentinel lymph node biopsy in patients with ductal carcinoma in situ and microinvasion
000565 (2012) A. P. T. Van Der Ploeg [Pays-Bas] ; A. C. J. Van Akkooi [Pays-Bas] ; P. Rutkowski [Pologne] ; M. Cook [Royaume-Uni] ; O. E. Nieweg [Pays-Bas] ; C. R. Rossi [Italie] ; A. Testori [Italie] ; S. Suciu [Belgique] ; C. Verhoef [Pays-Bas] ; A. M. M. Eggermont [France]Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection
000775 (2010) Y. Moghaddam [Royaume-Uni] ; M. Falzon [Royaume-Uni] ; L. Fulford [Royaume-Uni] ; N. R. Williams [Royaume-Uni] ; M. R. Keshtgar [Royaume-Uni]Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer
000818 (2009) Rajmohan Murali [Australie] ; Alistair J. Cochran [États-Unis] ; Martin G. Cook [Royaume-Uni] ; Joseph D. Hillman [États-Unis] ; Rooshdiya Z. Karim [Australie] ; Marc Moncrieff [Australie] ; Hans Starz [Allemagne] ; John F. Thompson [Australie] ; Richard A. Scolyer [Australie]Inter-observer reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma
000980 (2007) George M. Filippakis [Royaume-Uni] ; George Zografos [Grèce]Contraindications of sentinel lymph node biopsy: Áre there any really?
000A51 (2006) L. Calabrese [Italie] ; R. Bruschini [Italie] ; M. Ansarin [Italie] ; G. Giugliano [Italie] ; C. De Cicco [Italie] ; F. Ionna [Italie] ; G. Paganelli [Italie] ; F. Maffini [Italie] ; Ja Werner [Allemagne] ; D. Soutar [Royaume-Uni]Role of sentinel lymph node biopsy in oral cancer
000B34 (2005) Anand David Purushotham [Royaume-Uni] ; Sara Upponi ; Manfred Borislav Klevesath ; Lynda Bobrow ; Keith Millar ; Jonathan Peter Myles ; Stephen William DuffyMorbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
000B48 (2005) D. Sahni [Royaume-Uni] ; A. Robson ; G. Orchard ; R. Szydlo [Royaume-Uni] ; A V Evans [Royaume-Uni] ; R. Russell-Jones [Royaume-Uni]The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status
000B91 (2004) Amit Goyal [Royaume-Uni] ; Robert E. Mansel [Royaume-Uni]Current status of sentinel lymph node biopsy in solid malignancies
000C02 (2004) Tiziana Catzeddu [Italie] ; Gianfilippo Bertelli [Royaume-Uni] ; Lucia Del Mastro [Italie] ; Marco Venturini [Italie]Sentinel lymph node biopsy in breast cancer patients: The medical oncology perspective
000E54 (2001) Chi-Kin Chung [Royaume-Uni] ; Wai-Ka Hung ; Miranda Chi-Mui Chan ; Yvonne Lau ; Kong-Ling Mak ; Andrew Wai-Chun YipEarly experience of sentinel lymph node biopsy in breast cancer with blue dye technique
000E80 (2000) Sd Pendry [Royaume-Uni]A radiographer's perspective of sentinel lymph node biopsy
001086 (1998) David N. Krag [Royaume-Uni]Minimal access surgery for staging regional lymph nodes: The sentinel-node concept
001260 (1995) C. A. Stone [Royaume-Uni] ; C. A. Goodacre [Royaume-Uni]Surgical management of regional lymph nodes in primary cutaneous malignant melanoma
001371 (1993) R. N. Scott [Royaume-Uni] ; A. J. Mckay [Royaume-Uni]Elective lymph node dissection in the management of malignant melanoma
001616 (1987) G. Kissin [Royaume-Uni] ; D. A. Simpson [Royaume-Uni] ; D. Easton [Royaume-Uni] ; H. White ; G. Westbury [Royaume-Uni]Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma
000089 (2016) Mina M G. Youssef [Royaume-Uni] ; Diane Cameron [Royaume-Uni] ; Philip H. Pucher [Royaume-Uni] ; Sisse Olsen [Royaume-Uni] ; Douglas Ferguson [Royaume-Uni]The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
000170 (2015) Nazera Dodia [Royaume-Uni] ; Deena El-Sharief ; Cliona C. Kirwan [Royaume-Uni]The use of isotope injections in sentinel node biopsy for breast cancer: are the 1- and 2-day protocols equally effective?
000258 (2015) Alexandros Laios [Royaume-Uni] ; Davide Volpi [Royaume-Uni] ; Iain D. C. Tullis [Royaume-Uni] ; Martha Woodward [Royaume-Uni] ; Stephen Kennedy [Royaume-Uni] ; Pubudu N. J. Pathiraja [Royaume-Uni] ; Krishnayan Haldar [Royaume-Uni] ; Borivoj Vojnovic [Royaume-Uni] ; Ahmed A. Ahmed [Royaume-Uni]A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system
000468 (2013) Laura Johnson [Royaume-Uni] ; Sarah E. Pinder [Royaume-Uni] ; Michael Douek [Royaume-Uni]Deposition of superparamagnetic iron‐oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection
000594 (2011) Anastasia Pazaiti [Royaume-Uni] ; Ian S. Fentiman [Royaume-Uni]Which Patients Need an Axillary Clearance after Sentinel Node Biopsy?
000614 (2011) Katherine M. Burnand [Royaume-Uni] ; Daphne M. Glass ; Sumati Sundaraiya ; Peter S. Mortimer ; A Michael PetersPopliteal node visualization during standard pedal lymphoscintigraphy for a swollen limb indicates impaired lymph drainage.
000670 (2011) M. C. Swan [Royaume-Uni] ; D. W. Oliver [Royaume-Uni] ; O. C. S. Cassell [Royaume-Uni] ; D. J. Coleman [Royaume-Uni] ; N. Williams [Royaume-Uni] ; D. G. Morritt [Royaume-Uni] ; H. P. Giele [Royaume-Uni]Randomized controlled trial of fibrin sealant to reduce postoperative drainage following elective lymph node dissection
000681 (2011) D. M. Layfield [Royaume-Uni] ; A. Agrawal [Royaume-Uni] ; H. Roche [Royaume-Uni] ; R. I. Cutress [Royaume-Uni]Intraoperative assessment of sentinel lymph nodes in breast cancer
000698 (2011) Katherine M. Burnand [Royaume-Uni] ; Daphne M. Glass [Royaume-Uni] ; Sumati Sundaraiya [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni] ; A. Michael Peters [Royaume-Uni]Popliteal Node Visualization During Standard Pedal Lymphoscintigraphy for a Swollen Limb Indicates Impaired Lymph Drainage
000767 (2010) S. Nicholson [Royaume-Uni]New anatomical classification of the axilla with implications for sentinel node biopsy (Br J Surg 2010; 97: 1659–1665)
000777 (2010) R. Clapham [Royaume-Uni] ; E. O'Sullivan [Royaume-Uni] ; R. O. Weller [Royaume-Uni] ; R. O. Carare [Royaume-Uni]Cervical lymph nodes are found in direct relationship with the internal carotid artery: Significance for the lymphatic drainage of the brain
000799 (2009) Alireza Hamidian Jahromi [Royaume-Uni] ; Sankaran Narayanan [Royaume-Uni] ; Fiona Macneill [Royaume-Uni] ; Peter Osin [Royaume-Uni] ; Ashutash Nerurkar [Royaume-Uni] ; Gerald Gui [Royaume-Uni]Testing the Feasibility of Intra-Operative Sentinel Lymph Node Touch Imprint Cytology
000902 (2008) Amit Goyal [Royaume-Uni] ; Robert G. Newcombe ; Alok Chhabra ; Robert E. ManselMorbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
000941 (2008) Christopher P. Allan [Royaume-Uni, Australie] ; Andrew J. Hayes [Royaume-Uni] ; J. Meirion Thomas [Royaume-Uni]ILIOINGUINAL LYMPH NODE DISSECTION FOR PALPABLE METASTATIC MELANOMA TO THE GROIN
000959 (2007) Robert M. Kirby [Royaume-Uni] ; Abdul Basit [Royaume-Uni] ; Quang T. Nguyen [Royaume-Uni] ; Anthony Jaipersad [Royaume-Uni] ; Rebecca Billingham [Royaume-Uni]Three stage axillary lymphatic massage optimizes sentinel lymph node localisation using blue dye
000A25 (2007) Robert G. Newcombe [Royaume-Uni]Bayesian estimation of false‐negative rate in a clinical trial of sentinel node biopsy
000B27 (2005) A. Adwani [Royaume-Uni] ; Sr Ebbs [Royaume-Uni] ; S. Burton [Royaume-Uni] ; S. Lowe [Royaume-Uni]Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers
000B51 (2005) R. Russell-Jones [Royaume-Uni]Sentinel node and survival in melanoma
000C33 (2004) G. Cserni [Hongrie] ; I. Amendoeira [Portugal] ; N. Apostolikas [Grèce] ; J P Bellocq [France] ; S. Bianchi [Italie] ; W. Boecker [Allemagne] ; B. Borisch [Suisse] ; C E Connolly [Irlande (pays)] ; T. Decker [Allemagne] ; P. Dervan [Irlande (pays)] ; M. Drijkoningen [Belgique] ; I O Ellis [Royaume-Uni] ; C W Elston [Royaume-Uni] ; V. Eusebi [Italie] ; D. Faverly [Belgique] ; P. Heikkila [Finlande] ; R. Holland [Pays-Bas] ; H. Kerner [Israël] ; J. Kulka [Hongrie] ; J. Jacquemier [France] ; M. Lacerda [Portugal] ; J. Martinez-Penuela [Espagne] ; C. De Miguel [Espagne] ; J L Peterse [Pays-Bas] ; F. Rank [Danemark] ; P. Regitnig [Autriche] ; A. Reiner [Autriche] ; A. Sapino [Italie] ; B. Sigal-Zafrani [France] ; A M Tanous [Luxembourg (pays)] ; S. Thorstenson [Suède] ; E. Zozaya [Espagne] ; G. Fejes [Hongrie] ; C A Wells [Royaume-Uni]Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology
000E24 (2001) D. Clarke [Royaume-Uni] ; R. Mansel [Royaume-Uni]Sentinel node biopsy in breast cancer
000F11 (2000) T. M. D. Hughes [Royaume-Uni] ; R. P. A'Hern [Royaume-Uni] ; J. M. Thomas [Royaume-Uni]Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma
000F90 (1999) G. Howard-Alpe [Royaume-Uni]Sentinel Node Localization and Biopsy in Breast Cancer
001009 (1999) M. R. S. Keshtgar [Royaume-Uni] ; C. Saunders [Royaume-Uni] ; P. J. Ell [Royaume-Uni] ; M. Baum [Royaume-Uni]Langer's axillary arch in association with sentinel lymph node
001018 (1999) T. M. D. Hughes [Royaume-Uni] ; T. M. D. Thomas [Royaume-Uni]Combined inguinal and pelvic lymph node dissection for stage III melanoma
001088 (1998) S. A. Mcintosh [Royaume-Uni] ; S. A. Purushotham [Royaume-Uni]Lymphatic mapping and sentinel node biopsy in breast cancer
000005 (2017) Christos Iavazzo [Royaume-Uni] ; Paraskevi-Evangelia Iavazzo [Grèce] ; Ioannis D. Gkegkes [Grèce]The possible role of the da Vinci robot for patients with vulval carcinoma undergoing inguinal lymph node dissection
000025 (2017) Roberta Bianchi [Royaume-Uni] ; Erica Russo [Royaume-Uni] ; Samia B. Bachmann [Royaume-Uni] ; Steven T. Proulx [Royaume-Uni] ; Marko Sesartic [Royaume-Uni] ; Nora Smaadahl [Royaume-Uni] ; Steve P. Watson [Royaume-Uni] ; Christopher D. Buckley [Royaume-Uni] ; Cornelia Halin [Royaume-Uni] ; Michael Detmar [Royaume-Uni]Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes.
000050 (2017) C. Kunte [Allemagne] ; V. Letulé [Allemagne] ; J. Gehl [Danemark] ; K. Dahlstroem [Danemark] ; P. Curatolo [Italie] ; R. Rotunno [Italie] ; T. Muir [Royaume-Uni] ; A. Occhini [Italie] ; G. Bertino [Italie] ; B. Powell [Royaume-Uni] ; W. Saxinger [Autriche] ; G. Lechner [Autriche] ; S-H Liew [Royaume-Uni] ; R. Pritchard-Jones [Royaume-Uni] ; P. Rutkowski [Pologne] ; M. Zdzienicki [Pologne] ; D. Mowatt ; A J Sykes [Royaume-Uni] ; A. Orlando [Royaume-Uni] ; G. Mitsala [Royaume-Uni] ; C R Rossi [Italie] ; L. Campana [Italie] ; M. Brizio [Italie] ; F. De Terlizzi [Italie] ; P. Quaglino [Italie] ; J. Odili [Royaume-Uni]Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT.
000055 (2017) Damian Mullan [Royaume-Uni] ; Damir Kosutic [Royaume-Uni]Contrast CT-scan for preoperative planning of VSLN (vascularized submental lymph-node) transfer.
000156 (2016) Mia Schmidt-Hansen [Royaume-Uni] ; Nathan Bromham [Royaume-Uni] ; Elise Hasler [Royaume-Uni] ; Malcolm W. Reed [Royaume-Uni]Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
000211 (2015) Nigel J. Bundred [Royaume-Uni] ; Nicola L P. Barnes [Royaume-Uni] ; Emiel Rutgers [Pays-Bas] ; Mila Donker [Pays-Bas]Is axillary lymph node clearance required in node-positive breast cancer?
000230 (2015) Jk Dickson [Royaume-Uni] ; A. Davies [Royaume-Uni] ; S. Rahman [Royaume-Uni] ; C. Sethu [Royaume-Uni] ; Jro Smith [Royaume-Uni] ; A. Orlando [Royaume-Uni] ; D. Ayers [Royaume-Uni]Dissections of regional lymph nodes for treatment of skin cancer: predicting annual caseloads that will optimise outcomes
000260 (2015) S K Bains [Royaume-Uni] ; A W B. Stanton [Royaume-Uni] ; V. Cintolesi [Royaume-Uni] ; J. Ballinger [Royaume-Uni] ; S. Allen [Royaume-Uni] ; C. Zammit [Royaume-Uni] ; J R Levick [Royaume-Uni] ; Peter Mortimer (dermatologue)‎ [Royaume-Uni] ; A M Peters [Royaume-Uni] ; A D Purushotham [Royaume-Uni]A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow.
000280 (2014) Adam S. Baumgarten [États-Unis] ; Eihab Alhammali [États-Unis] ; Tariq S. Hakky [États-Unis] ; Patrick N. Espiritu [États-Unis] ; Julio M. Pow-Sang [États-Unis] ; Wade J. Sexton [États-Unis] ; Jorge L. Lockhart [États-Unis] ; Chris Protzel [Allemagne] ; Oliver Hakenberg [Allemagne] ; Asif Muneer [Royaume-Uni] ; Philippe E. Spiess [États-Unis]Salvage surgical resection for isolated locally recurrent inguinal lymph node metastasis of penile cancer: international study collaboration.
000337 (2014) Cécile Bénézech ; Saba Nayar ; Brenda A. Finney [Royaume-Uni] ; David R. Withers ; Kate Lowe [Royaume-Uni] ; Guillaume E. Desanti ; Clare L. Marriott ; Steve P. Watson [Royaume-Uni] ; Jorge H. Caama O ; Christopher D. Buckley ; Francesca BaroneCLEC-2 is required for development and maintenance of lymph nodes
000390 (2013) Darren K. Patten [Royaume-Uni] ; Daniel R. Leff ; Zubair Wani ; Susan J. Cleator ; Carlo Palmieri ; R Charles Coombes ; Dimitri J. HadjiminasIs the presence of small volume disease in the sentinel node an indication for axillary clearance?
000416 (2013) Amit Goyal [Royaume-Uni] ; Lelia Duley [Royaume-Uni] ; Apostolos Fakis [Royaume-Uni]Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol
000473 (2013) P. De Mozzi ; P. Da Forno ; N. Yii [Royaume-Uni] ; K. HarmanAn unusual complication of axillary lymph‐node clearance
000580 (2012) H. Powell [Royaume-Uni] ; V. K. Affolter [États-Unis]Combined decongestive therapy including equine manual lymph drainage to assist management of chronic progressive lymphoedema in draught horses
000612 (2011) Elly Brockbank [Royaume-Uni] ; Fani Kokka [Royaume-Uni] ; Andrew Bryant [Royaume-Uni] ; Christophe Pomel [France] ; Karina Reynolds [Royaume-Uni]Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer
000613 (2011) K L Cooper [Royaume-Uni] ; S. Harnan ; Y. Meng ; S E Ward ; P. Fitzgerald ; D. Papaioannou ; L. Wyld ; C. Ingram ; I D Wilkinson ; E. LorenzPositron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
000639 (2011) Y. Meng [Royaume-Uni] ; S. Ward ; K. Cooper ; S. Harnan ; L. WyldCost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
000668 (2011) J. R. Benson [Royaume-Uni] ; G. C. Wishart [Royaume-Uni]Role of axillary clearance for patients with sentinel node‐positive early breast cancer
000731 (2010) Dean Fulford [Royaume-Uni] ; Sam Dalal [Royaume-Uni] ; John Winstanley [Royaume-Uni] ; Mike J. Hayton [Royaume-Uni]Hand surgery after axillary lymph node clearance for breast cancer: contra-indication to surgery?
000760 (2010) Stephen M. Kihara [Royaume-Uni] ; Neil A. Giblett [Royaume-Uni] ; Catriona Mcneil ; Paul Crea [Australie]Sentinel node micrometastases in breast cancer: Clinical outcome
000766 (2010) M. R. S. Keshtgar [Royaume-Uni] ; D. W. Chicken [Royaume-Uni] ; M. R. Austwick [Royaume-Uni] ; S. K. Somasundaram [Royaume-Uni] ; C. A. Mosse [Royaume-Uni] ; Y. Zhu [Royaume-Uni] ; I. J. Bigio [États-Unis] ; S. G. Bown [Royaume-Uni]Optical scanning for rapid intraoperative diagnosis of sentinel node metastases in breast cancer
000808 (2009) Ian H. Kunkler [Royaume-Uni]Radiotherapy of the regional lymph nodes: shooting at the sheriff?
000821 (2009) A S Ali-Khan [Royaume-Uni] ; M. Crundwell ; C. StoneInguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma.
000907 (2008) Benjamin Bird [États-Unis] ; Milos Miljkovic [États-Unis] ; Melissa J. Romeo [États-Unis] ; Jennifer Smith [Royaume-Uni] ; Nicholas Stone [Royaume-Uni] ; Michael W. George [Royaume-Uni] ; Max Diem [États-Unis]Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology
000A38 (2007) Anand D. Purushotham [Royaume-Uni] ; Thomas M. Bennett Britton [Royaume-Uni] ; Manfred B. Klevesath [Royaume-Uni] ; Patrick Chou [Royaume-Uni] ; Olorunsola F. Agbaje [Royaume-Uni] ; Stephen W. Duffy [Royaume-Uni]Lymph node status and breast cancer-related lymphedema
000A43 (2006) J. Balega [Royaume-Uni] ; P O Van Trappen [Royaume-Uni]The sentinel node in gynaecological malignancies
000B25 (2005) Simon J. Pain [Royaume-Uni] ; Robert W. Barber ; Chandra K. Solanki ; James R. Ballinger ; Tom Bennett Britton ; Peter S. Mortimer ; Anand D. Purushotham ; A Michael PetersShort-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer.
000B29 (2005) Stephanie Modi [Royaume-Uni] ; Anthony W. B. Stanton [Royaume-Uni] ; Russell H. Mellor [Royaume-Uni] ; A. Michael Peters ; J. Rodney Levick [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni]Regional Distribution of Epifascial Swelling and Epifascial Lymph Drainage Rate Constants in Breast Cancer-Related Lymphedema
000C19 (2004) J E A. Somner [Royaume-Uni] ; J M J. Dixon [Royaume-Uni] ; J S J. Thomas [Royaume-Uni]Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status
000C56 (2003) Mary Woods [Royaume-Uni]The experience of manual lymph drainage as an aspect of treatment for lymphoedema.
000C67 (2003) A. W. B. Stanton ; R. H. Mellor ; G. J. Cook ; W. E. Svensson ; A. M. Peters ; J. R. Levick [Royaume-Uni] ; Peter Mortimer (dermatologue)‎ [Royaume-Uni]Impairment of Lymph Drainage in Subfascial Compartment of Forearm in Breast Cancer-Related Lymphedema
000D87 (2001) A W Stanton [Royaume-Uni] ; W E Svensson ; R H Mellor ; A M Peters ; J R Levick ; Peter Mortimer (dermatologue)‎ [Royaume-Uni]Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema.
000E30 (2001) S. P. Harden [Royaume-Uni] ; A. J. Neal [Royaume-Uni] ; N. Al-Nasiri [Royaume-Uni] ; S. Ashley [Royaume-Uni] ; G. Querci Della Rovere [Royaume-Uni]Predicting axillary lymph node metastases in patients with T1infiltrating ductal carcinoma of the breast
000F39 (2000) D. J. Simmons [Royaume-Uni] ; S. M. Wharton [Royaume-Uni]Compartment syndrome complicating metastatic malignant melanoma
000F57 (1999) C. Yiangou ; S. Shousha [Royaume-Uni] ; H D SinnettPrimary tumour characteristics and axillary lymph node status in breast cancer
001062 (1998) A. E. Hawley [Royaume-Uni] ; L. Illum [Royaume-Uni] ; S. S. Davis [Royaume-Uni]The effect of lymphatic oedema on the uptake of colloids to the lymph nodes
001068 (1998) George W. Flett [Royaume-Uni] ; J. J. Going [Royaume-Uni] ; P. D. Stanton [Royaume-Uni] ; T. G. Cooke [Royaume-Uni]Sentinel node localization in patients with breast cancer
001091 (1998) A. T. Slater [Royaume-Uni]Histological demarcation of lateral borders: an unsupportable criterion for distinguishing malignant melanoma from Spitz naevus and compound naevus
001226 (1995) Peter Mortimer (dermatologue)‎ [Royaume-Uni]Evaluation of lymphatic function: abnormal lymph drainage in venous disease.
001264 (1995) R. A Aabroe [Royaume-Uni] ; P. Dorman [Royaume-Uni] ; D. Harlow [Royaume-Uni] ; I. E. C. Ormerod [Royaume-Uni] ; C. T. C. Kennedy [Royaume-Uni]Polymyositis and malignant melanoma
001276 (1995) Alexandru E. Sterne [Royaume-Uni] ; D. S. Murray [Royaume-Uni] ; R. P. Grimley [Royaume-Uni]Ilioinguinal block dissection for malignant melanoma
001387 (1993) R. H. Bull [Royaume-Uni] ; J. N. Gane [Royaume-Uni] ; J. E. C. Evans [Royaume-Uni] ; A. E. A. Joseph [Royaume-Uni] ; Peter Mortimer (dermatologue)‎ [Royaume-Uni]Abnormal lymph drainage in patients with chronic venous leg ulcers
001520 (1990) H. Marcus [Royaume-Uni] ; J. Pawade [Royaume-Uni] ; E. J. Vella [Royaume-Uni]Painful lymphatic occlusion following axillary lymph node surgery
001529 (1990) R. H. Bull ; Peter Mortimer (dermatologue)‎ [Royaume-Uni] ; J. Gane ; A. G. A. JosephAbnormal lymph drainage in patients with chronic venous leg ulcers
001687 (1984) Frances Browse [Royaume-Uni] ; R. L. Doig [Royaume-Uni] ; D. Sizeland [Royaume-Uni]The resistance of a lymph node to lymph flow
001689 (1984) Neil R. Mclean [Royaume-Uni] ; John G. Boorman [Royaume-Uni]Secondary malignant melanoma arising in a contralateral thigh donor site
001691 (1984) M. S. Khan [Royaume-Uni] ; W. M. Ross [Royaume-Uni]Management of malignant melanoma: A retrospective analysis of 182 patients
001738 (1978) J. M. Edwards [Royaume-Uni] ; P. J. Pheils [Royaume-Uni]ENDOLYMPHATIC ISOTOPE AND BCG IN THE MANAGEMENT OF MALIGNANT MELANOMA
001778 (1970) D. Negus [Royaume-Uni] ; J. M. Edwards [Royaume-Uni] ; J. B. Kinmonth [Royaume-Uni]Filling of cervical and mediastinal nodes from the thoracic duct and the physiology of virchow's node—studies by lymphography

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024